Curosurf 120 mg, suspension pour instillation

7680518860117 CH-51886 suspension
Curosurf 120 mg, suspension pour instillation
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1 x 1,5 mL
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
23/12/2025
Summary of Product Characteristics
Français
23/12/2025
Summary of Product Characteristics
Italien
23/12/2025

Detailed composition

Substance Quantity Type Category
poractantum alfa
120.0 MG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
natrii hydrogenocarbonas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Chiesi SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
51886
Drug name
Curosurf, suspension pour instillation endotrachéobronchique
Galenic form
SUEN
ATC Code
R07AA02
Authorization status
Z
Dispensing category
A
First authorization
07/07/1993
Authorization expiration date
31/12/9999
IT Number
03.99.0.
Domain
Human medicine
Field of application
Atemnotsyndrom des Frühgeborenen (Surfaktant)

Package details

Description (FR)
CUROSURF susp instill 120 mg/1.5ml amp 1.5 ml
Description (DE)
CUROSURF Instill Susp 120 mg/1.5ml Amp 1.5 ml
Market launch
07/07/1993
Narcotic (BTM)
No
Buy us a coffee Explore the data